1. Home
  2. Southern Africa
  3. South Africa

Cabinet seeks solution on Nevirapine

South African Health Minister Manto Tshabalala-Msimang is currently discussing the efficacy of the anti-AIDS drug, Nevirapine, with drug manufacturers, provincial health ministers and other stakeholders.

The minister told the recent AIDS conference in Bangkok that the single-dose drug, used nationwide to combat mother-to-child transmission of HIV, led to resistance.

As a result, the cabinet has given Tshabalala-Msimang until the end of July to determine a new direction on the use of Nevirapine.

Cabinet spokesman Joel Netshitenzhe told a local newspaper, Business Day, that HIV-positive mothers receiving the single dose of the drug would now be "more vigorously" informed of the risks of developing resistance to Nevirapine.


This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

Share this article

Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

Become a member of The New Humanitarian

Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

Join